Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Tau: At the Interface Between Neurodegeneration and Cancer?

Version 1 : Received: 15 October 2020 / Approved: 16 October 2020 / Online: 16 October 2020 (12:31:41 CEST)

How to cite: Papin, S.; Paganetti, P. Tau: At the Interface Between Neurodegeneration and Cancer?. Preprints 2020, 2020100349 (doi: 10.20944/preprints202010.0349.v1). Papin, S.; Paganetti, P. Tau: At the Interface Between Neurodegeneration and Cancer?. Preprints 2020, 2020100349 (doi: 10.20944/preprints202010.0349.v1).

Abstract

For its microtubule-binding properties, the expression level of the neurodegeneration-associated protein Tau is pondered as a potential modifier of cancer resistance to chemotherapy since decades. Indeed, Tau binds microtubules at the same site as taxanes, a class of chemotherapeutic drugs designed to stabilize the microtubule network in order to stall cell division and to induce tumor cell death. Whilst independent studies report the association between low Tau expression and superior taxane response, the data were refused by a meta-analysis, suggesting interference of other parameters. Unpredictably, Tau expression level was identified as a prognostic cancer marker, whereby its positive or negative predictive value for survival depended on the cancer type. With recent experimental evidence linking Tau to P53 signaling, DNA stability and protection and to the implication of Tau in cancer is strengthened. The identification of a role of Tau at the interface between two major aging-related disorder families, neurodegeneration and cancer, offers clues for the epidemiological observation inversely correlating these disorders. Elucidating how Tau is mechanistically implicated in cellular pathways common to these devastating illnesses may extend the Tau-targeting therapeutic opportunities to cancer.

Subject Areas

neurodegeneration; tauopathies; cancer, Tau protein, DNA protection

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.